KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 - 药物、适应症、专利

基本信息

关联

1

项与 KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 相关的药物

Asudemotide

靶点

DEPDC1 x IGF2BP3 x KIF20B x LY6K x NUF2

作用机制

DEPDC1抑制剂 [+4]

在研机构

OncoTherapy Science, Inc. [+1]

原研机构

OncoTherapy Science, Inc.

在研适应症

食管癌 [+2]

非在研适应症-

最高研发阶段临床3期

首次获批国家/地区-

首次获批日期1800-01-20

5

项与 KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 相关的临床试验

JPRN-UMIN000023324

/ Completed临床1期

Exploratory study to determine S-588410-induced tumor infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients - Exploratory study to determine S-588410-induced tumor infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients

开始日期2016-07-25

申办/合作机构

Shionogi & Co., Ltd.

JPRN-UMIN000016954

/ Completed临床3期

A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of S-588410 as adjuvant therapy after curative resection in patients with esophageal cancer - A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of S-588410 as adjuvant therapy after curative resection in patients with esophageal cancer

开始日期2015-05-01

申办/合作机构

Shionogi & Co., Ltd.

NCT02410369

/ Unknown status临床2期IIT

Phase II Study of S-588410 as Maintenance Monotherapy After Adjuvant Chemotherapy in Patients With Completely Resected Non-small- Cell Lung Cancer

In this clinical study, the investigators evaluate the efficacy and safety of S-588410 in patients who underwent an adjuvant chemotherapy after the complete resection of non-small-cell lung cancer.

开始日期2015-03-01

申办/合作机构

University of Tokyo

[+5]

100 项与 KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 相关的临床结果

登录后查看更多信息

100 项与 KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 相关的转化医学

登录后查看更多信息

0 项与 KIF20B x IGF2BP3 x LY6K x NUF2 x DEPDC1 相关的专利（医药）

登录后查看更多信息

分析

对领域进行一次全面的分析。

登录

或

查看完整样例数据